Skip to main content

SUSQUEHANNA INTERNATIONAL GROUP, LLP

Position in SLN — Silence Therapeutics plc

CIK 1446194 BALA CYNWYD, PA

Position in SLN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$2,026,018
+$1,418,488 QoQ
Shares Held
184,519
+60.1% QoQ
Ownership
0.297%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#25
of 72 holders
Holding Since
Jun 2025
4 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in SLN Over Time

Shares Held

Position Value (USD)

Derivatives in SLN

reported options exposure · as of Jun 30, 2026
CallValue
$213,012
CallShares
19,400
PutValue
$327,204
PutShares
29,800

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $1,649,997,309 across 349 Biotechnology names. SLN ranks #84 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in SLN

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $213,012 19,400
2026-06-30 $2,026,018 184,519
2026-06-30 $327,204 29,800
2026-03-31 $607,530 115,281
2026-03-31 $99,603 18,900
2026-03-31 $106,454 20,200
2025-12-31 $152,000 25,000
2025-12-31 $102,545 16,866
2025-06-30 $161,222 27,797